Related Experiment Video
Updated: Feb 13, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability
Cosimo Lobello1, Vasilis Bikos2, Andrea Janikova3
1Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. cosimo.lobello@ceitec.muni.cz.
Abstract:
Genomic stability is crucial for cell life and transmitting genetic material is one of the primary tasks of the cell. The cell needs to be able to recognize any possible error and quickly repair it, and thus, cells have developed several mechanisms to detect DNA damage and promote repair during evolution. The DNA damage response (DDR) and DNA repair pathways ensure the control of possible errors that could impair the duplication of genetic information and introduce variants in the DNA. Endogenous and exogenous factors compromise genomic stability and cause dysregulation in the DDR and DNA repair pathways. Cancer cells often impair these mechanisms to overcome cellular barriers (cellular senescence and/or apoptosis), leading to malignancy. NPM (nucleophosmin)-ALK (anaplastic lymphoma kinase) is an oncogenic tyrosine kinase that is involved in the development of anaplastic large cell lymphoma (ALCL). NPM-ALK is known to be involved in the activation of proliferative and anti-apoptotic signaling pathways. New evidence reveals that NPM-ALK translocation also impairs the ability of cells to maintain the genomic stability through both DDR and DNA repair pathways. This review aims to highlight the role of the oncogenic tyrosine kinase NPM-ALK in the cell, and pointing to new possible therapeutic strategies.
Insights
Genomic stability is maintained by DNA damage response (DDR) and repair pathways. The oncogenic NPM-ALK tyrosine kinase disrupts these crucial pathways, potentially leading to anaplastic large cell lymphoma (ALCL) and offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Genomic stability is vital for cell survival and accurate genetic material transmission.
- Cells possess sophisticated DNA damage response (DDR) and DNA repair mechanisms to counteract endogenous and exogenous damaging factors.
- Dysregulation of DDR and DNA repair pathways is a hallmark of cancer, enabling uncontrolled proliferation and malignancy.
Purpose of the Study:
- To review the role of the oncogenic tyrosine kinase NPM (nucleophosmin)-ALK (anaplastic lymphoma kinase) in cellular processes.
- To elucidate how NPM-ALK impacts genomic stability through DDR and DNA repair pathways.
- To identify potential new therapeutic strategies targeting NPM-ALK in cancer, particularly anaplastic large cell lymphoma (ALCL).
Main Methods:
- Literature review focusing on NPM-ALK, genomic stability, DDR, and DNA repair.
- Analysis of existing evidence on the molecular mechanisms of NPM-ALK.
- Synthesis of findings to highlight therapeutic implications.
Main Results:
- NPM-ALK is an oncogenic tyrosine kinase implicated in anaplastic large cell lymphoma (ALCL) development.
- NPM-ALK activates proliferative and anti-apoptotic signaling pathways.
- Evidence indicates NPM-ALK translocation impairs cellular genomic stability by affecting DDR and DNA repair pathways.
Conclusions:
- NPM-ALK plays a significant role in compromising genomic stability.
- The disruption of DDR and DNA repair by NPM-ALK contributes to cancer progression.
- Targeting NPM-ALK presents a promising avenue for novel cancer therapies.
Related Concept Videos
Receptor Tyrosine Kinases
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Genomics
Microtubule Instability

